Geneos Wealth Management’s AdvisorShares Pure Cannabis ETF YOLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.5K Sell
34,810
-16,050
-32% -$47.7K ﹤0.01% 1200
2025
Q4
$168K Buy
50,860
+47,100
+1,253% +$152K ﹤0.01% 978
2025
Q3
$13.3K Buy
+3,760
New +$10.5K ﹤0.01% 1868
2025
Q1
Sell
-220
Closed -$532 3175
2024
Q4
$532 Hold
220
﹤0.01% 2876
2024
Q3
$717 Hold
220
﹤0.01% 2505
2024
Q2
$741 Hold
220
﹤0.01% 2017
2024
Q1
$898 Hold
220
﹤0.01% 2046
2023
Q4
$664 Hold
220
﹤0.01% 2063
2023
Q3
$752 Hold
220
﹤0.01% 2060
2023
Q2
$565 Buy
+220
New +$597 ﹤0.01% 2059
2021
Q2
Sell
-641
Closed -$13K 3142
2021
Q1
$13K Sell
641
-1,047
-62% -$25.1K ﹤0.01% 2277
2020
Q4
$38K Buy
+1,688
New +$24K ﹤0.01% 1595

Other funds holding YOLO

Geneos Wealth Management's YOLO Position: Q1 2026 in Review

Geneos Wealth Management reduced its AdvisorShares Pure Cannabis ETF (YOLO) stake by 32% in Q1 2026, selling an estimated $47.7K and leaving 34,810 shares worth $91.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

Geneos Wealth Management first reported a position in YOLO in Q4 2020 and has held it in 12 quarters since. The position peaked at $168K in Q4 2025. 54 funds tracked by Wall St. Rank hold YOLO as of Q1 2026.

  • Geneos Wealth Management held 34,810 shares of AdvisorShares Pure Cannabis ETF worth $91.5K as of Q1 2026.
  • Geneos Wealth Management sold 16,050 AdvisorShares Pure Cannabis ETF shares in Q1 2026, an estimated $47.7K.
  • AdvisorShares Pure Cannabis ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1200 holding.
  • Geneos Wealth Management first reported a position in AdvisorShares Pure Cannabis ETF in Q4 2020 and has held it in 12 quarters since.
  • Geneos Wealth Management's AdvisorShares Pure Cannabis ETF position peaked at $168K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held AdvisorShares Pure Cannabis ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.